ClinicalTrials.Veeva

Menu

Evaluating the Long-term Effects of Microfocused Ultrasound on Facial Tightening Using Quantitative Instruments

J

Jinan University

Status

Completed

Conditions

Facial Aging

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

A non-randomized, evaluator-blinded study was conducted to observe the changes in the face before and after facial rejuvenation using microfocused ultrasound. The efficacy of microfocused ultrasound in facial rejuvenation was evaluated using standardized photographs in conjunction with a dermatological testing system and to explore the effects of microfocused ultrasound on the function of the skin.

Full description

Primary efficacy endpoints:Utilizing the 3D Life Viz mini system for standardized photo modeling enables the comparison and identification of enhancements in treatment outcomes. This research utilized standardized photo modeling to record the facial and mandibular conditions of patients, capturing images both before and after treatment (immediately post-operation and at 7, 30, 90, 180,270 and 360 days). The detection of improvements in treatment effects was then achieved through pairwise comparisons of the modeled data derived from these photographs;Secondary efficacy endpoints: Global Aesthetic Improvement Scale, patient satisfaction scores, Digital Visual Analog Scale

Enrollment

30 patients

Sex

Female

Ages

25 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Ages between 25 and 60 years old.
  2. Clear manifested skin issues such as sagging and wrinkles: Merz Facial Aesthetics Score of 2 or above.
  3. Absence of significant systemic diseases, cardiovascular disorders, impaired liver or kidney function, malignant tumors, etc.
  4. Willing to participate in this study and sign an informed consent form.

Exclusion criteria

  1. Pregnant or lactating women.
  2. Individuals with a scar-prone constitution, allergic or abnormally healing skin.
  3. Treatment areas with damaged skin, acute inflammation, active infection, rosacea, vitiligo in the progressive stage, or severe acne.
  4. Patients with skin conditions such as urticaria, itching, or other dermatological diseases.
  5. Those with psychological disorders or drug allergies.
  6. Individuals harboring unrealistic expectations about treatment outcomes.
  7. Treatment areas containing metal foreign bodies or fillers deemed unsuitable for treatment by the physician.
  8. Recent facial laser treatments or injections within the past month, including but not limited to filler treatments such as hyaluronic acid, botulinum toxin, and PRP injection therapy.
  9. Any skin-tightening cosmetic treatments on the face or neck within the last three months.
  10. Any minimally invasive cosmetic treatments on the face within the last three months.
  11. Thread embedding treatments on the face within the last year, excluding thread blepharoplasty.
  12. Patients with severe insomnia or those requiring intense sun exposure within the next three months.
  13. Patients deemed unsuitable for participation by the investigator.
  14. Those unable to cooperate with the treatment and complete all required visits.

Trial contacts and locations

1

Loading...

Central trial contact

Xuangu LI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems